Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,735
archived clinical trials in
Psoriasis

Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Michigan Center for Skin Care Research
mi
from
Clinton Township, MI
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Michigan Center for Skin Care Research
mi
from
Clinton Township, MI
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Dermatology Consulting Services
mi
from
High Point, NC
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Dermatology Consulting Services
mi
from
High Point, NC
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Radiant Research, Inc.
mi
from
Cincinnati, OH
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Radiant Research, Inc.
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Oregon Medical Research Center, PC
mi
from
Portland, OR
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Oregon Medical Research Center, PC
mi
from
Portland, OR
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Oregon Dermatology & Research Center
mi
from
Portland, OR
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Oregon Dermatology & Research Center
mi
from
Portland, OR
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Clinical Partners, LLC
mi
from
Johnston, RI
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Clinical Partners, LLC
mi
from
Johnston, RI
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Rhode Island Hospital
mi
from
Providence, RI
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Radiant Research
mi
from
Greer, SC
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Radiant Research
mi
from
Greer, SC
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Health Concepts
mi
from
Rapid City, SD
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Health Concepts
mi
from
Rapid City, SD
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Dermatology Research Associates
mi
from
Nashville, TN
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Dermatology Research Associates
mi
from
Nashville, TN
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Arlington Research Center
mi
from
Arlington, TX
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Arlington Research Center
mi
from
Arlington, TX
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Dermatology Treatment & Research Center, PA
mi
from
Dallas, TX
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Dermatology Treatment & Research Center, PA
mi
from
Dallas, TX
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Menter Dermatology Research Institute
mi
from
Dallas, TX
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Menter Dermatology Research Institute
mi
from
Dallas, TX
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Suzanne Bruce & Associates, PA
mi
from
Houston, TX
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Suzanne Bruce & Associates, PA
mi
from
Houston, TX
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Progressive Clinical Research
mi
from
San Antonio, TX
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Progressive Clinical Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Lee Medical Associates
mi
from
San Antonio, TX
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Lee Medical Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Bakersfield Dermatology and Skin Cancer Medical Center
mi
from
Bakersfield, CA
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Bakersfield Dermatology and Skin Cancer Medical Center
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Stratica Medical
mi
from
Edmonton,
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Stratica Medical
mi
from
Edmonton,
Click here to add this to my saved trials
The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis
The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis
Status: Enrolling
Updated:  11/3/2015
UC Davis Department of Dermatology
mi
from
Sacramento, CA
The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis
The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis
Status: Enrolling
Updated: 11/3/2015
UC Davis Department of Dermatology
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Indianapolis, IN
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
San Diego, CA
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Miami, FL
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Alpharetta, GA
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Alpharetta, GA
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Arlington Heights, IL
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Arlington Heights, IL
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Chicago, IL
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Norfolk, VA
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Louisville, KY
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Louisville, KY
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Bay City, MI
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Bay City, MI
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
New York, NY
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Charlotte, NC
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Cleveland, OH
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Portland, OR
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Charleston, SC
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Charleston, SC
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
College Station, TX
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
College Station, TX
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Anniston, AL
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Anniston, AL
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated:  11/20/2015
Clinical Research Facility
mi
from
Birmingham, AL
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated: 11/20/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated:  11/20/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated: 11/20/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated:  11/20/2015
Clinical Research Facility
mi
from
San Diego, CA
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated: 11/20/2015
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated:  11/20/2015
Clinical Research Facility
mi
from
Denver, CO
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated: 11/20/2015
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated:  11/20/2015
Clinical Research Facility
mi
from
Atlanta, GA
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated: 11/20/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated:  11/20/2015
Clinical Research Facility
mi
from
Louisville, KY
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated: 11/20/2015
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated:  11/20/2015
Clinical Research Facility
mi
from
Henderson, NV
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated: 11/20/2015
Clinical Research Facility
mi
from
Henderson, NV
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated:  11/20/2015
Clinical Research Facility
mi
from
Bronx, NY
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated: 11/20/2015
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated:  11/20/2015
Clinical Research Facility
mi
from
Houston, TX
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated: 11/20/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated:  11/20/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated: 11/20/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated:  11/20/2015
Clinical Research Facility
mi
from
Mobile, AL
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated: 11/20/2015
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated:  11/20/2015
Clinical Research Facility
mi
from
Beverly Hills, CA
Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-3
Status: Enrolling
Updated: 11/20/2015
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials